Athersys (ATHX) Soars On Stem Cell Development Deal with Pfizer
Tweet Send to a Friend
Athersys, Inc. (Nasdaq: ATHX) is a huge mover this morning on an agreement with Pfizer Inc. (NYSE: PFE) to develop ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
